CNNM3 and kidney cancer: To assess the effect of ARL15 on CNNM3 N-glycosylation, four different kidney cancer cell lines were used: Caki-1 and RCC4 as well as ACHN and SK-RC-39, belonging to clear cell renal cell carcinoma and papillary renal cell carcinoma, respectively.